<ѻý>Predicting Disease Recurrence in Melanomaѻý> But time to recurrence may poorly correlate with survival May 03, 2019
<ѻý>Omitting Chemo Feasible in First-Line HER2+ Breast Cancer?ѻý> De-escalation showed mixed results in metastatic disease May 01, 2019
<ѻý>PET Imaging Top Choice for Detecting Parathyroid Adenomasѻý> Study compared method to two other techniques Apr 26, 2019
<ѻý>Marcia Cross of 'Desperate Housewives' Opens Up on Anal Cancerѻý> Actress discloses her survival story and wants to end the stigma Apr 18, 2019
<ѻý>'Magic Mouthwash' Little Help for Radiation-Induced Mucositisѻý> Only statistical improvements in pain scores for head and neck cancer patients Apr 16, 2019
<ѻý>Aggressive Therapy at End of Life Common in Cancerѻý> Little or no benefit for patients who died within 30 days of diagnosis Apr 15, 2019
<ѻý>I Have Cancer. Please Don't Call Me a 'Survivor'ѻý> No chemo, no radiation, no symptoms, a few biopsies -- hardly the stuff of heroism Apr 15, 2019
<ѻý>Practice 'Cultural Humility' in End-of-Life Conversationsѻý> Clinicians should know the limits of their cultural understanding Apr 12, 2019
<ѻý>Vaccine Clears HPV-Infected Cervical Lesionsѻý> Complete clearance in a fourth of precancerous CIN2/3 Apr 09, 2019
<ѻý>Rheumatologist's Primer on Checkpoint Inhibitorsѻý> Specialist reviews the landscape of cancer drugs' autoimmune side effects Apr 09, 2019
<ѻý>Bone Marrow Transplant for Autoimmune Disease: Ready for Prime Time?ѻý> Everything you know about BMT is probably wrong, says hematologist Apr 08, 2019
<ѻý>Can Virtual Reality Head Off Pre-Op Anxiety?ѻý> Promising results from randomized trial in colorectal cancer patients Apr 05, 2019
<ѻý>Durable Responses With Keytruda in Later-Line SCLCѻý> Plus umbralisib in marginal zone lymphoma and a next-generation TRK-targeted agent Apr 04, 2019
<ѻý>Genetic Variant Tied to Stroke After Brain Irradiationѻý> Tripled stroke risk in survivors of childhood cancers Apr 04, 2019
<ѻý>Birth Control Pills Tied to Reduced Risk of Deadly Ovarian Caѻý> Every 5 years of use linked with 32% reduction in risk of dying within 12 months of diagnosis Apr 04, 2019 video
<ѻý>PARP Inhibitor Maintenance for Pancreatic Cancerѻý> Study takes cue from new treatment paradigm in BRCA-mutant ovarian cancer Apr 03, 2019
<ѻý>Reversing Melanoma Resistance to Immunotherapyѻý> HDAC inhibitor/anti-PD-1 combo active after initial anti-PD-1 failure Apr 02, 2019 video
<ѻý>Overall Survival Data in for Gilteritinib as AML Salvage Txѻý> FLT3 Inhibitor tops chemotherapy in randomized trial Apr 01, 2019
<ѻý>MET Inhibitor Rescues Some Targeted Tx Failures in NSCLCѻý> Savolitinib promising in patients with MET-based resistance to EGFR inhibition Apr 01, 2019 video
<ѻý>CAR T-Cell Therapy Active in Solid Tumorsѻý> Preliminary data on safety, efficacy in mesothelioma, sarcomas Mar 31, 2019 video
<ѻý>Aggressive Tx Remains Common for Adults, Children Near Deathѻý> Many patients continue with treatments they probably don't need Mar 30, 2019
<ѻý>Transplant No Help in Hypodiploid ALLѻý> Similar 5-year outcomes with or without HSCT, regardless of MRD status Mar 29, 2019
<ѻý>Are Patients Better Off With Image-Guided Bone Marrow Biopsy?ѻý> Prospect of sedation has some going to interventional radiology Mar 29, 2019
<ѻý>Digital Rectal Exams: Worth the Trouble?ѻý> Howard Wolinsky looks for the evidence, and doesn't find much Mar 29, 2019
<ѻý>Potential Game Changer for Endometrial Cancerѻý> A 30% response rate in recurrent/advanced disease, 49% in MSI-H tumors Mar 20, 2019
<ѻý>Early Data Send Strong Signal in Advanced Gyn Cancersѻý> Clinical benefit rate tops 90% in pair of single-center studies Mar 19, 2019
<ѻý>'End of the Road' for Trabectedin in Ovarian Cancer?ѻý> Trial stopped for futility, but 13-month OS improvement seen in patients with BRCA mutations Mar 19, 2019
<ѻý>When PARP Inhibitors Fail in Ovarian Cancerѻý> Study identifies subgroup for whom another go could be worthwhile Mar 18, 2019
<ѻý>Avelumab Combo Falls Short in Advanced Ovarian Caѻý> But showed promise in PD-L1-positive group Mar 18, 2019
<ѻý>Ticagrelor Antidote Clears Phase I Trialѻý> Quick reversal of P2Y12 inhibitor possible in healthy participants Mar 17, 2019
<ѻý>PARP Inhibitor Benefit Gets a TWiST in Recurrent Ovarian Caѻý> Analysis attempts to quantify patients' quality of survival Mar 17, 2019
<ѻý>No Rise in Cancer Risk for RA Patients on Actemraѻý> Similar to malignancy risk with TNF inhibitors and abatacept Mar 14, 2019
<ѻý>Aggressive Tx in Oligometastatic NSCLC Tied to Improved OSѻý> Histology, intrathoracic disease burden, and bone metastases may predict outcomes Mar 12, 2019
<ѻý>Cancer Drug for Precancerous Lesions?ѻý> Fluorouracil cream bested other common actinic keratosis treatments Mar 08, 2019
<ѻý>Vaccine Prolongs Remission in Triple-Negative Breast Cancerѻý> Effect in hard-to-treat subgroup "clinically meaningful" Mar 07, 2019
<ѻý>Monkees' Peter Tork Dies of Rare Salivary Gland Cancerѻý> But what is adenoid cystic carcinoma? Mar 07, 2019
<ѻý>Do Keloids Convey a Higher Cancer Risk?ѻý> Taiwanese researchers show association between raised scars and cancers Mar 03, 2019
<ѻý>Lymphadenectomy Often Useless in Ovarian Cancerѻý> No survival benefit with normal nodes after complete macroscopic resection Mar 01, 2019
<ѻý>Black History Month: Talking With Jennifer Webb, MDѻý> How mentorship helped her overcome barriers Feb 28, 2019
<ѻý>Liquid Biopsy Matches Tissue for NSCLC Guidanceѻý> Increased mutation detection rate, faster turnaround time Feb 27, 2019